Results 11 to 20 of about 116,199 (152)

Unusual location of an intracranial chondroma. [PDF]

open access: yesAJNR Am J Neuroradiol, 1997
We describe the MR findings in a case of chondroma arising from the falx. At MR imaging, the mass appeared well defined, lobulated, hypointense to isointense on T1-weighted images, and very heterogeneous with marked hyperintense areas on T2-weighted images. After contrast administration, this tumor enhanced slightly on delayed images.
De Coene B   +5 more
europepmc   +3 more sources

Chondroma of Falx: Case Report of a Rare Condition [PDF]

open access: yesActa Medica Iranica, 2012
Chondroma is a benign tumor which mostly occurs in extremities but also sometimes in brain. Most intracranial chondromas arise from skull base, but chondroma of falx origin is a rare circumstance.
Ata Abbasi   +4 more
doaj   +2 more sources

Giant dural supratentorial chondroma generating the question of how large can a tumor become without revealing itself

open access: yesClinics and Practice, 2015
Chondromas usually affect the small bones of hand and feet and account for only 0.5% of all intracranial tumors. We present a case of a giant, supratentorial meningeal chondroma in a 19-year old male patient and discuss the preoperative diagnostic ...
Alexandros Doukas   +7 more
doaj   +2 more sources

Meningeal chondroma in a young female

open access: yesIndian Journal of Pathology and Microbiology, 2010
Meningeal chondroma is a rare intracranial neoplasm. It is usually diagnosed clinically as meningioma. Histologically it may have a differential diagnosis of chordoid meningioma, a malignant lesion, and needs radiotherapy.
Kumari Niraj   +2 more
doaj   +1 more source

Calcified Chondroid Mesenchymal Neoplasm of the Temporomandibular Joint: A Rare and Recently Described Benign Tumor. [PDF]

open access: yesCase Rep Otolaryngol
The calcified chondroid mesenchymal neoplasm (CCMN) was first recognized as a distinct pathologic entity in 2021 at the University of Washington, and fewer than 100 cases of CCMN have been described in the literature. The CCMN tumor is characterized by the presence of chondroid matrix elements with an FN1–receptor TK gene fusion. CCMNs frequently arise
Yuan J, Lazaro T, Sekhar LN, Lee KC.
europepmc   +2 more sources

Intracranial Falcine Chondroma: A Case Report and Review of The Literature

open access: yes, 2012
Intracranial chondromas are rare neoplasms that are most commonly located at the skull base. Localization of this tumor in other areas, such as the convexity, falcine area, brain parenchyma or ventricles is less common. These slow-growing benign tumors have nonspecific symptoms, and variable radiological findings.
Durak, Merih Güray   +5 more
core   +4 more sources

A Soft Tissue Osteochondrolipoma of the Lateral Ankle: A Case Report and Clinical Insight. [PDF]

open access: yesCase Rep Orthop
Tumors of the foot and ankle are uncommon, accounting for approximately 4%–10% of all musculoskeletal tumors; most are benign soft‐tissue lesions. Osteochondrolipoma is an exceptionally rare histological variant of lipoma characterized by mature adipose tissue with cartilaginous and osseous differentiation.
Luthfi APWY   +6 more
europepmc   +2 more sources

Case report: Rare convexity meningeal chondroma mimicking a meningioma. [PDF]

open access: yesSurg Neurol Int, 2021
Background: Intracranial chondromas account for 0.2-0.3% of all intracranial neoplastic lesions and less than a quarter arise in the convexity or falx. Despite its benign nature, exceedingly rare malignant transformations exist.
Abreu PG   +7 more
europepmc   +2 more sources

The Reibergram for immunoglobulin A in dogs: Evaluation of intrathecal IgA synthesis using a quotient graph in dogs with neurological diseases

open access: yesJournal of Veterinary Internal Medicine, Volume 37, Issue 1, Page 191-203, January/February 2023., 2023
Abstract Background Increased cerebrospinal fluid (CSF) protein concentration is a common finding in neurological diseases of dogs. Distinguishing between intrathecally‐produced proteins and proteins that have passed the blood‐CSF barrier because of barrier disruption facilitates diagnosis.
Mirja L. Püschel   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy